Skip to main content
SpringerLink
Log in

Rivastigmine improves activities of daily living in Alzheimer's disease

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rivastigmine improves activities of daily living in Alzheimer's disease. Pharmacoecon. Outcomes News 353, 9 (2002). https://doi.org/10.1007/BF03278798

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03278798

Keywords

Search

Navigation